Loading clinical trials...
Loading clinical trials...
An Open Label, Prospective, Observational, Non-interventional Study of Bevacizumab in Combination With Interferon Alpha-2a for the First-line Treatment of Patients With Advanced and/or Metastatic Renal Cell Carcinoma
Conditions
Locations
2
India
Aurangabad, India
Delhi, India
Start Date
August 1, 2010
Primary Completion Date
August 1, 2011
Completion Date
August 1, 2011
Last Updated
October 4, 2017
NCT06391099
NCT06349642
NCT04473781
NCT07227415
NCT07294859
NCT07190638
Lead Sponsor
Hoffmann-La Roche
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions